ADVERTISEMENT
Q&A, functional genomics, genetic privacy, bioinformatics, data science, Yale School of Medicine, Genetics & Genomics
Q&A: A New Tool for Ensuring Genetic Privacy
Gamze Gursoy and Mark Gerstein of Yale Medical School have developed a strategy for stripping identifying variants from functional genomic data, balancing privacy with utility.
Q&A: A New Tool for Ensuring Genetic Privacy
Q&A: A New Tool for Ensuring Genetic Privacy

Gamze Gursoy and Mark Gerstein of Yale Medical School have developed a strategy for stripping identifying variants from functional genomic data, balancing privacy with utility.

Gamze Gursoy and Mark Gerstein of Yale Medical School have developed a strategy for stripping identifying variants from functional genomic data, balancing privacy with utility.

23andMe
slavery, human population genetics, 23andMe, genomics, African American, Black history, history
African American Genomes Yield Insight into Slavery Practices
Amanda Heidt | Jul 23, 2020 | 5 min read
A massive study finds that regional differences in how slaves were treated throughout the Americas are reflected in the DNA of present-day Americans of African descent.
MyHeritage Launches Health-Related Genetic Test, Ignites Debate
Catherine Offord | Jul 9, 2019 | 8 min read
Its screen for selected variants of some disease-linked genes gives customers an incomplete picture of their risk—do they know?
Startups Plan the Health Data Gold Rush
Shawna Williams | Oct 1, 2018 | 8 min read
Companies are building platforms based on blockchain technology to let individuals control and directly profit from their genomic and medical information.
Opinion: Consumer DNA Testing Is Crossing into Unethical Territories
John D. Loike | Aug 16, 2018 | 4 min read
Data don’t support many direct-to-consumer products, from telomere assessments to bespoke diets based on genetic sequences.
MyHeritage Account Data Compromised in “Cybersecurity Incident”
Catherine Offord | Jun 6, 2018 | 2 min read
A security researcher found the email addresses and encrypted passwords of more than 92 million users of the genealogy site on a private server outside the company.
Companies to Help People Sell or Rent Out Their Health Data
Catherine Offord | Jun 5, 2018 | 2 min read
Luna DNA, Nebula Genomics, and other “bio-brokers” will allow customers to make money by granting access to their genetic and personal information for research purposes.
Opinion: No, FDA Didn’t Really Approve 23andMe’s BRCA Test
Cecile Janssens | Mar 19, 2018 | 3 min read
Rather, the breast cancer mutation screen was classified as a type of medical device with obligations for the company to reduce risks to customers.
First Direct-to-Consumer BRCA Test Authorized by FDA
Kerry Grens | Mar 6, 2018 | 2 min read
The agency gave personal genomics company 23andMe the green light to screen samples for breast cancer–related genetic mutations.
The Rising Research Profile of 23andMe
Catherine Offord | Nov 30, 2017 | 7 min read
An exploration of the genetics of earlobe attachment is just the latest collaborative research project to come out of the personal genetic testing company.
FDA OKs Marketing of DTC Genetic Health-Risk Tests
Diana Kwon | Apr 7, 2017 | 2 min read
23andMe customers can now receive information about genetic risk for diseases including Parkinson’s and celiac.
Pooling Consumer Genetic Data, Researchers ID Links to Depression
Alison F. Takemura | Aug 2, 2016 | 2 min read
Access to data from thousands of genotyping customers helped scientists detect novel associations with the disorder across the genome.
23andMe Markets Genome Kits to Researchers
Kerry Grens | Jul 14, 2016 | 1 min read
Scientists can now buy the direct-to-consumer sequencing product, and research participants can join 23andMe’s database.
Genetic Connections Among Human Traits
Anna Azvolinsky | May 16, 2016 | 3 min read
A study identifies genetic variants that are linked to multiple phenotypes.
Genetic Resilience
Tanya Lewis | Apr 11, 2016 | 3 min read
An analysis of the genomes of nearly 600,000 healthy individuals reveals a handful of people who appear resistant to certain genetic disorders.
GWAS IDs “Morning People”
Catherine Offord | Feb 3, 2016 | 1 min read
In a large genome-wide association study, researchers from 23andMe locate 15 DNA regions associated with people’s preferences for early morning starts.
Following FDA OK, 23andMe to Expand Health Prediction
Kerry Grens | Oct 21, 2015 | 2 min read
The personal genomics firm is ramping up its suite of disease-related genetic tests.
23andMe Enters Drug Development
Kerry Grens | Mar 12, 2015 | 2 min read
The personal genomics firm announces plans to make medicines.
FDA OKs 23andMe Test
Kerry Grens | Feb 20, 2015 | 1 min read
The US Food and Drug Administration will allow the personal genomics company to resume a disease-risk analysis.
23andMe Partners with Pfizer
Jef Akst | Jan 13, 2015 | 1 min read
The personal genomics company strikes yet another deal to glean biomedically relevant information from its user data.
ADVERTISEMENT